Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of glucocorticoids in ventilator-associated pneumonia
2007-005948-24Phase 4Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ventilator-associated pneumonia (VAP) and pneumonia comparing Methylprednisolone arm with Placebo arm (2 arms). Primary endpoint: Empirical antimicrobial treatment failure rate at 72 hours. Started Jan 2008; status: active.
02
Drugs
methylprednisolone
03
Conditions
ventilator-associated pneumonia (VAP)pneumonia
Beyond the preview
Go deeper on 2007-005948-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005948-24.